B
United Therapeutics Corporation UTHR
$307.24 $1.850.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 21.35% 23.46% 22.71% 44.24% 35.40%
Total Depreciation and Amortization 36.28% 26.19% 16.06% 5.37% 3.70%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 216.67% 10.32% -1.20% -68.70% -77.10%
Change in Net Operating Assets 38.45% -57.29% 22.08% -126.13% 30.74%
Cash from Operations 35.70% 18.95% 27.39% 10.25% 21.87%
Capital Expenditure -6.99% -24.74% -17.19% -36.43% -65.99%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 265.93% 219.79% 230.45% 209.18% 40.54%
Cash from Investing 157.98% 161.25% 152.49% 135.16% 11.32%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -300.00% -- -- -- 87.50%
Issuance of Common Stock 53.06% -7.20% -25.61% -43.30% 10.92%
Repurchase of Common Stock -7,234.78% -7,286.86% -7,231.88% -7,231.16% -21.05%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00% 0.00% 0.00% 0.00% 64.00%
Cash from Financing -10,444.54% -1,033.21% -984.54% -935.93% -115.78%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 98.58% 216.68% 5.99% -74.87% 271.23%
Weiss Ratings